|
|
???tair.name??? >
???browser.page.title.author???
|
"jy chang"???jsp.browse.items-by-author.description???
Showing items 1-23 of 23 (1 Page(s) Totally)
1
View [10|25|50] records per page
| 亞洲大學 |
2016-03 |
miR-520h is crucial for DAPK2 regulation and breast cancer progression
|
蘇智銘;CM, Su;MY, Wang;MY, Wang;CC, Hong;CC, Hong;HA, Chen;HA, Chen;YH, Su;YH, Su;CH, Wu;CH, Wu;MT, Huang;MT, Huang;YW, Chang;YW, Chang;Jiang SS;Sung SY;JY, Chang;JY, Chang;LT, Chen;LT, Chen;PS, Chen;PS, Chen;蘇振良* |
| 臺北醫學大學 |
2014 |
Antimitotic and vascular disrupting agents: 2-hydroxy-3,4,5-trimethoxybenzophenones
|
CY, Chang;HY, Chuang;HY, Lee;TK, Yeh;CC, Kuo;CY, Chang;JY, Chang;JP, Liou |
| 臺北醫學大學 |
2014 |
Orally active microtubule-targeting agent, MPT0B271, for the treatment of human non-small cell lung cancer, alone and in combination with erlotinib
|
AC, Tsai;CY, Wang;JP, Liou;HC, Pai;CJ, Hsiao;JY, Chang;JC, Wang;CM, Teng;SL, Pan |
| 臺北醫學大學 |
2014 |
Azaindolylsulfonamides, with a More Selective Inhibitory Effect on Histone Deacetylase 6 Activity, Exhibit Antitumor Activity in Colorectal Cancer HCT116 Cells
|
HY, Lee;AC, Tsai;MC, Chen;PJ, Shen;YC, Cheng;CC, Kuo;SL, Pan;YM, Liu;JF, Liu;TK, Yeh;JC, Wang;CY, Chang;JY, Chang;JP, Liou |
| 臺北醫學大學 |
2014 |
?Reconstruction of exposed cohort and cumulative dose of radio-contaminated building residents for epidemiological study - Updated information
|
SO, Chiang;CH, Chen;CJ, Tung;Chou, P;Whang-Peng, J;HY, Chiou;CJ, Chen;YH, Chen;LH, Yu;JY, Chang;Jyuhn-Hsiarn, Lee L;SH, Liou |
| 臺北醫學大學 |
2014 |
Fabrication of metamaterial absorber using polymer brush – gold nanoassemblies for visualizing the reversible pH-responsiveness
|
GY, Zhou;AW, Lee;JY, Chang;CH, Huang;JK*, Chen |
| 中國醫藥大學 |
2013-11 |
Formalin-inactivated EV71 vaccine candidate induced cross-neutralizing antibody responses against subgenotypes B1, B4, B5 and C4A in adult volunteers
|
(Ai-Hsiang Chou);(CC Liu);(JY Chang);(WH Yang);(R Jiang R);(YC Hsieh);(A Tsao);(CL Wu CL);(JL Huang);(SC Lin);(TC Lu);(YF Wang YF);(CF Fung);(SM Hsieh);(Wang JR);(MH Hu);(JR Chiang);(IJ Su);莊再成(Pele Chong)* |
| 臺北醫學大學 |
2013 |
Dissecting the EGFR-P13K-AKT pathway in oral cancer highlights the roles of the EGFR variant III and its clinical relevance
|
KY, Chang;SY, Tsia;SH, Chen;HH, Tsou;CJ, Yen;KJ, Liu;HL, Fang;HC, Wu;BF, Chuang;SW, Chou;CK, Tang;SY, Liu;PJ, Lu;CY, Yen;JY, chang |
| 臺北醫學大學 |
2013 |
MPT0B098, a novel microtubule inhibitor that destabilizes the hypoxia-inducible factor-1α mRNA through decreasing nuclear-cytoplasmic translocation of RNA-binding protein HuR
|
YC, Cheng;JP, Liou;CC, Kuo;WY, Lai;KH, Shih;CY, Chang;WY, Pan;JT, Tseng;JY, Chang |
| 臺北醫學大學 |
2013 |
Furanylazaindoles: Potent Anticancer Agents in Vitro and in Vivo
|
Lee, HY;Pan, SL;Su, MC;Liu, YM;Kuo, CC;Chang, YT;Wu, JS;Nien, CY;Mehndiratta, S;Chang, CY;Wu, SY;Lai, MJ;JY*, Chang;JP*, Liou |
| 臺北醫學大學 |
2013 |
A novel synthetic microtubule inhibitor, MPT0B214 exhibits antitumor activity in human tumor cells through mitochondria-dependent intrinsic pathway
|
NJ, Chiang;CI, Lin;JP, Liou;CC, Kuo;CY, Chang;LT, Chen;JY, Chang |
| 臺北醫學大學 |
2013 |
Furanylazaindoles: Potent Anticancer Agents in Vitro and in Vivo
|
HY, Lee;SL, Pan;MC, Su;YM, Liu;CC, Kuo;YT, Chang;JS, Wu;CY, Nien;Mehndiratta, S;CY, Chang;SY, Wu;MJ, Lai;JY*, Chang;JP*, Liou |
| 臺北醫學大學 |
2012 |
ARYL SUBSTITUTED SULFONAMIDE COMPOUNDS AND THEIR USE AS ANTICANCER AGENTS
|
JP, Liou;JY, Chang |
| 臺北醫學大學 |
2011 |
2-Amino-3,4,5-Trimethoxybenzophenones as Potent Tubulin Polymerization Inhibitors
|
HY, Chuang;JY, Chang;MJ, Lai;CC, Kuo;HY, Lee;HP, Hsieh;YJ, Chen;LT, Chen;WY, Pan;JP, Liou |
| 臺北醫學大學 |
2011 |
5-Amino-2-aroylquinolines as Highly Potent Tubulin Polymerization Inhibitors
|
HY, Lee;JY, Chang;CY, Nien;CC, Kuo;KH, Shih;CH, Wu;CY, Chang;WY, Lai;JP, Liou |
| 臺北醫學大學 |
2011 |
Concise syntheses of N-aryl-5,6,7-trimethoxyindoles as antimitotic and vascular disrupting agents: application of the copper-mediated Ullmann-type arylation
|
HY, Lee;JY, Chang;LY, Chang;WY, Lai;MJ, Lai;KH, Shih;CC, Kuo;CY, Chang;JP, Liou |
| 臺北醫學大學 |
2011 |
Synthesis and biological evaluation of 1-(40-Indolyl and 60-Quinolinyl) indoles as a new class of potent anticancer agents.
|
MJ, Lai;JY, Chang;HY, Lee;CC, Kuo;MH, Lin;HP, Hsieh;CY, Chang;JS, Wu;SY, Wu;Shey;KS;JP, Liou |
| 臺北醫學大學 |
2011 |
Synthesis and Biological Evaluation of 1-(4’-Indolyl and 6’-Quinolinyl)indoles as a New Class of Potent Anticancer Agents
|
MJ, Lia;JY, Chang;HY, Lee;CC, Kuo;MH, Lin;HP, Hsieh;CY, Chang;JS, Wu;SY, Wu;KS, Shey;JP, Liou |
| 臺北醫學大學 |
2011 |
Synthesis and Biological Evaluation of 4-Aroyl-6,7,8-Trimethoxyquinolines as a Novel Class of Anticancer Agents
|
CC, Hsieh;HY, Lee;CY, Nien;CC, Kuo;CY, Chang;JY, Chang;JP, Liou |
| 臺北醫學大學 |
2011 |
Antimutagenic Constituents of Adlay (Coix lachryma-jobi L. var. ma-yuen Stapf) with Potential Cancer Chemopreventive Activity
|
HH, Chen;WC, Chiang;JY, Chang;YL, Chien;CK, Lee;KJ, Liu |
| 臺北醫學大學 |
2010 |
5-Amino-2-Aroylquinolines as Highly Potent Tubulin Polymerization Inhibitors
|
CY, Nien;YC, Chen;CC, Kuo;HP, Hsieh;CY, Chang;JS, Wu;SY, Wu;JP, Liou;JY, Chang |
| 高雄醫學大學 |
2003 |
子宮頸癌細胞中Caveolin-1基因突變或甲基化與Caveolin-1蛋白質表現相關性分析
|
詹德富;蘇聰賢;葉坤土;張建裕;林亭序;陳瑞彰;袁行修;張建國 ; Te-Fu Chan;TH Su;KT Yeh;JY Chang;TH Lin;JC Chen;SS Yuan;JG Chang |
| 中山醫學大學 |
2002 |
The correlation between CpG methylation on promoter and protein expression of E-cadherin in oral squamous cell carcinoma
|
KT, Yeh;MC, Shih;TH, Lin;JC, Chen;JY, Chang;CF, Kao;KL, Lin;JG, Chang |
Showing items 1-23 of 23 (1 Page(s) Totally)
1
View [10|25|50] records per page
|
